Weinshenker B - Search Results

1

Update on biomarkers in neuromyelitis optica.

Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, Nakashima, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S. Melamed E, et al. Among authors: weinshenker b. Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e134. doi: 10.1212/NXI.0000000000000134. eCollection 2015 Aug. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26236760 Free PMC article. Review.

2

Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis.

Weinshenker BG, Wingerchuk DM, Liu Q, Bissonet AS, Schaid DJ, Sommer SS. Weinshenker BG, et al. Neurology. 1997 Aug;49(2):378-85. doi: 10.1212/wnl.49.2.378. Neurology. 1997. PMID: 9270565

3

A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis.

Wingerchuk D, Liu Q, Sobell J, Sommer S, Weinshenker BG. Wingerchuk D, et al. Among authors: weinshenker bg. Neurology. 1997 Aug;49(2):626-8. doi: 10.1212/wnl.49.2.626. Neurology. 1997. PMID: 9270614

4

Clinical outcome measures and rating scales in multiple sclerosis trials.

Wingerchuk DM, Noseworthy JH, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Mayo Clin Proc. 1997 Nov;72(11):1070-9. doi: 10.4065/72.11.1070. Mayo Clin Proc. 1997. PMID: 9374984 Review.

5

The clinical course of neuromyelitis optica (Devic's syndrome).

Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Neurology. 1999 Sep 22;53(5):1107-14. doi: 10.1212/wnl.53.5.1107. Neurology. 1999. PMID: 10496275

6

The natural history of multiple sclerosis: implications for trial design.

Wingerchuk DM, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Curr Opin Neurol. 1999 Jun;12(3):345-9. doi: 10.1097/00019052-199906000-00013. Curr Opin Neurol. 1999. PMID: 10499179 Review.

7

Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measures.

Wingerchuk DM, Weinshenker BG. Wingerchuk DM, et al. Among authors: weinshenker bg. Neuroimaging Clin N Am. 2000 Nov;10(4):611-24 ,vii. Neuroimaging Clin N Am. 2000. PMID: 11359715 Review.

8

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. Lucchinetti CF, et al. Among authors: weinshenker b. Brain. 2002 Jul;125(Pt 7):1450-61. doi: 10.1093/brain/awf151. Brain. 2002. PMID: 12076996 Free PMC article.

9

Neuromyelitis optica: clinical predictors of a relapsing course and survival.

Wingerchuk DM, Weinshenker BG. Wingerchuk DM, et al. Neurology. 2003 Mar 11;60(5):848-53. doi: 10.1212/01.wnl.0000049912.02954.2c. Neurology. 2003. PMID: 12629245

10

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. Lennon VA, et al. Lancet. 2004 Dec 11-17;364(9451):2106-12. doi: 10.1016/S0140-6736(04)17551-X. Lancet. 2004. PMID: 15589308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page